Introduction

Heart enlargement, or cardiomegaly, refers to an abnormal increase in the size of the heart.¹ It occurs when the heart's muscles become thickened or stretched due to increased workload. Common causes include high blood pressure, which forces the heart to pump harder; heart valve diseases that disrupt normal blood flow; and heart failure. In such conditions, the heart cannot efficiently pump blood to meet the body's needs. Over time, these factors lead to the heart enlarging as it tries to compensate for the extra strain, potentially leading to further complications.¹ 

Role of beta-blockers in cardiovascular health

Beta-blockers play a crucial role in cardiovascular health by reducing heart rate and blood pressure, thereby easing the strain on the heart.² They work by blocking the effects of adrenaline on beta receptors, helping to prevent arrhythmias and improve heart function.³ In the cases of heart enlargement, beta-blockers are especially important, as they help to manage the underlying conditions, such as high blood pressure and heart failure. They contribute to the heart's enlargement, ultimately slowing disease progression and improving long-term outcomes.¹

Understanding heart enlargement

Types of cardiomegaly

There are two main types of cardiomegaly, dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM).⁴ 

DCM occurs when the heart's chambers, particularly the left ventricle, become enlarged and weakened, reducing the heart’s ability to pump blood efficiently.⁴  It's often caused by conditions like coronary artery disease, chronic high blood pressure, or viral infections.⁴ 

HCM, on the other hand, involves the thickening of the heart muscle, especially the walls of the ventricles. This obstructs blood flow and makes it harder for the heart to fill with blood.^1,4 HCM is often genetic and can lead to symptoms like shortness of breath or arrhythmias.¹ 

Symptoms 

Symptoms of cardiomegaly (heart enlargement) can vary depending on the underlying cause and severity, but common signs include:^1,5 

• Shortness of breath
• Fatigue 
• Swelling (oedema)
• Irregular heartbeats (arrhythmias)
• Dizziness or light-headedness
• Chest pain or discomfort
• Coughing or wheezing

Risk factors of cardiomegaly

Key risk factors for cardiomegaly include:⁶

• Hypertension (high blood pressure): Forces the heart to work harder, leading to thickening and enlargement over time
• Coronary artery disease: Narrowed arteries reduce blood flow to the heart, weakening the heart muscle
• Heart valve disorders(diseases): Leaky or narrowed valves cause the heart to enlarge as it compensates for improper blood flow
• Alcohol abuse: Long-term heavy drinking weakens the heart muscle, increasing the risk of dilation
• Genetic conditions: A family history of cardiomyopathy can predispose individuals to heart enlargement
• Obesity: Excess body weight strains the heart, often contributing to high blood pressure and related conditions
• Infections or inflammation: Certain infections can damage the heart muscle, leading to enlargement

Mechanism of beta-blockers in treating heart enlargement

Reduction in heart rate

Beta-blockers primarily function to reduce heart rate, which in turn decreases the heart's strain. They block the action of adrenaline (epinephrine) on beta-adrenergic receptors, particularly the beta-1 receptors located in the heart. By doing so, they slow down the heart rate and decrease the force of contraction.¹ 

This reduction in heart rate allows the heart to pump more efficiently and with less effort, which is crucial for individuals with heart enlargement. A slower heart rate gives the heart more time to fill with blood, enhancing overall cardiac output while minimising oxygen demand. As a result, beta-blockers help alleviate symptoms associated with heart enlargement, such as shortness of breath and fatigue. It also prevents further progression of heart failure and related complications.⁷

Control of blood pressure

Beta-blockers play a critical role in controlling blood pressure, which is essential in managing heart enlargement.⁸ By blocking beta-adrenergic receptors, particularly beta-1 receptors in the heart and beta-2 receptors in blood vessels, these medications reduce cardiac output and relax blood vessels, leading to lower blood pressure.¹

Decreased blood pressure alleviates the strain on the heart, preventing further dilation and hypertrophy. This is particularly important in patients with conditions like hypertension (high blood pressure), where elevated pressure can exacerbate (make the condition worse) heart enlargement.¹ By effectively managing blood pressure, beta-blockers improve symptoms such as shortness of breath and fatigue. It also contributes to long-term heart health by reducing the risk of heart failure and other complications associated with cardiomegaly.⁹

Prevention of arrhythmias

Beta-blockers are effective in the prevention of arrhythmias, which are abnormal heart rhythms commonly seen in cardiomegaly. By blocking beta-adrenergic receptors in the heart, they help stabilise electrical conduction pathways, reducing the likelihood of irregular heartbeats.¹⁰ 

This stabilisation is crucial for patients with heart enlargement, as the enlarged heart can lead to disturbances in the electrical signals that regulate heart rhythm. By maintaining a more regular heart rhythm, beta-blockers improve overall cardiac function. Consequently, reduces the risk of potentially life-threatening arrhythmias, ultimately enhancing patient outcomes and quality of life.¹⁰ 

Types of beta-blockers used for heart enlargement

Non-selective beta-blockers

Propranolol

• Mechanism: Blocks both beta-1 and beta-2 receptors¹¹ 
• Usage: Commonly used in hypertrophic cardiomyopathy (HCM) to reduce heart rate and blood pressure¹² 

Carvedilol

• Mechanism: Has a dual action on both beta and alpha receptors, reducing heart rate and promoting vasodilation (widening of blood vessels)¹² 
• Usage: Frequently prescribed for dilated cardiomyopathy (DCM) and heart failure to improve cardiac function and decrease symptoms¹² 

Cardio-selective beta-blockers

Metoprolol

• Mechanism: Selectively blocks beta-1 adrenergic receptors primarily located in the heart, which reduces heart rate and contractility. This specificity minimises the effects on beta-2 receptors found in the lungs and blood vessels, making it safer for patients with respiratory issues¹³ 
• Usage: Commonly used in patients with hypertension and dilated cardiomyopathy, it has been shown to reduce mortality in heart failure patients by improving heart efficiency and preventing detrimental remodelling¹³  

Bisoprolol

• Mechanism: Another selective beta-1 blocker that decreases heart rate and myocardial oxygen demand by blocking beta-1 receptors. This leads to improved cardiac output and reduced workload on the heart¹³ 
• Usage: Frequently prescribed for heart failure and cardiomegaly to enhance survival rates and improve overall cardiac function, especially in patients with chronic heart conditions¹³  

Vasodilating beta-blockers

Nebivolol

• Mechanism: Nebivolol combines selective beta-1 adrenergic receptor blockade with vasodilatory properties.¹⁴ It not only reduces heart rate and contractility by blocking beta-1 receptors but also promotes the release of nitric oxide, leading to vasodilation.¹⁴ This dual action lowers blood pressure and decreases systemic vascular resistance, enhancing overall cardiac efficiency
• Usage: It is particularly beneficial in patients with dilated cardiomyopathy, as it improves heart function and reduces symptoms associated with heart failure. It may enhance exercise capacity while minimising adverse effects often seen with non-selective beta-blockers¹⁴ 

Potential side effects and considerations

Common side effects

Due to their significant influence on the heart and circulatory systems, beta-blockers can result in a variety of side effects. Consequently, healthcare providers often select specific beta-blockers to mitigate or prevent these adverse reactions.^3,11 

Some of these side effects include:³  

• Fatigue and dizziness 
• Poor circulation
• Bradycardia (slow heart rate) and hypotension (low blood pressure)
• Shortness of breath
• Sleep disturbances
• Gastrointestinal symptoms - These can include upset stomach, nausea, and constipation
• Sexual dysfunction
• Weight gain
• Irregular heart rhythms
• Worsening of heart failure symptoms in some cases - This is why careful monitoring is important, especially when starting treatment. 

Tailored action on the heart and blood vessels

Tailored action: The selection between non-selective and cardioselective beta-blockers depends on individual patient profiles and the specific type of cardiomegaly. Non-selective options are effective for conditions like hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), while cardioselective options are preferred for patients with respiratory issues.^3,11 

Patient monitoring

Patients on beta blockers require consistent follow-up to ensure the medication's effectiveness and safety. This typically involves:

Kidney function tests

Regular blood tests to assess eGFRcreatinine (estimated glomerular filtration rate) and ACR (albumin: creatinine ratio) are essential. These tests help monitor kidney health, which can be affected by heart conditions and certain medications.¹⁵ 

Blood pressure checks

Frequent blood pressure measurements are necessary to ensure the medication is effectively controlling hypertension without causing hypotension.³ 

Heart rate monitoring

Beta-blockers slow the heart rate, so regular checks are important to prevent bradycardia (excessively slow heart rate).³ 

Electrolyte levels

Periodic blood tests to check electrolyte balance, particularly potassium levels. These are important, as some beta blockers can affect electrolyte homeostasis (a state of balance).¹⁵ 

Liver function tests

Sometimes, beta-blockers may affect liver function, so occasional liver enzyme tests may be necessary.¹⁵ 

Contraindications

Beta-blockers are contraindicated in certain conditions due to the potential for adverse effects.

• Asthma: Asthma patients should avoid non-selective beta-blockers, as these can exacerbate bronchoconstriction³
• Severe hypotension: Beta-blockers can further lower blood pressure, which may be dangerous in patients with already low blood pressure^3,11
• Certain heart conduction issues: Beta-blockers can slow the heart rate and affect cardiac conduction. So they may be contraindicated in patients with severe bradycardia or certain types of heart block, such as atrioventricular (AV) block
• Chronic obstructive pulmonary disease (COPD): Similar to asthma, beta-blockers may worsen breathing difficulties in COPD patients
• Diabetes: Beta-blockers may mask symptoms of hypoglycaemia and should be used with caution in diabetic patients¹¹
• Pregnancy and breastfeeding: Beta-blockers can affect the baby’s heart rate and blood sugar levels and can pass into breast milk
• Uncontrolled heart failure: In individuals experiencing severe, decompensated heart failure, Beta-blockers should only be administered cautiously and after the patient has stabilised³

Summary

Beta-blockers are vital in the management of heart enlargement. It offers significant benefits in slowing disease progression, alleviating symptoms, and improving long-term outcomes for patients. By reducing heart rate, controlling blood pressure, and preventing arrhythmias, these medications help enhance overall cardiac function. However, the effectiveness of beta-blockers is closely linked to personalised treatment strategies.  It is essential to select the right type of beta-blocker based on individual patient profiles, specific heart conditions, and any comorbidities. This tailored approach ensures optimal therapeutic outcomes while minimising potential side effects, making beta-blockers a key component in the treatment of heart enlargement.